The endothelial tyrosine phosphatase SHP-1 plays an important role for vascular haemostasis in TNF α-induced inflammation in vivo

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Koch, Elisabeth ^a   Pircher, Joachim ^a,b   Czermak, Thomas ^a   Gaitzsch, Erik ^a   Alig, Stefan ^a   Mannell, Hanna ^b   Niemeyer, Markus ^c   Krötz, Florian ^d   Wörnle, Markus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d Klinikum Starnberg   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; STIBOGLUCONATE SODIUM; TUMOR NECROSIS FACTOR ALPHA; ANTIMONY GLUCONATE; PROTEIN TYROSINE PHOSPHATASE SHP 1;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; HEMOSTASIS; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; ENDOTHELIUM; METABOLISM; SWINE; THROMBOCYTE; WESTERN BLOTTING; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM;

MUS;

ANIMALS; ANTIMONY SODIUM GLUCONATE; BLOOD PLATELETS; BLOTTING, WESTERN; CELLS, CULTURED; ENDOTHELIUM; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878668162     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/279781     Document Type: Article

References (48)

1. Ross R., Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207
2. Libby P., Inflammation in atherosclerosis. Nature 2002 420 6917 868 874 2-s2.0-0037180771 10.1038/nature01323
3. Ohta H., Wada H., Niwa T., Kirii H., Iwamoto N., Fujii H., Saito K., Sekikawa K., Seishima M., Disruption of tumor necrosis factor- αgene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis 2005 180 1 11 17 2-s2.0-17044370386 10.1016/j.atherosclerosis. 2004.11.016
4. Iademarco M. F., Barks J. L., Dean D. C., Regulation of vascular cell adhesion molecule-1 expression by IL-4 and TNF- αin cultured endothelial cells. Journal of Clinical Investigation 1995 95 1 264 271 2-s2.0-0028861841
5. Zhang H., Park Y., Wu J., Chen X. P., Lee S., Yang J., Dellsperger K. C., Zhang C., Role of TNF- αin vascular dysfunction. Clinical Science 2009 116 3 219 230 2-s2.0-60549098432 10.1042/CS20080196
6. Goodwin B. L., Pendleton L. C., Levy M. M., Solomonson L. P., Eichler D. C., Tumor necrosis factor- αreduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells. American Journal of Physiology 2007 293 2 H1115 H1121 2-s2.0-34547912897 10.1152/ajpheart.01100.2006
7. Gao X., Belmadani S., Picchi A., Xu X., Potter B. J., Tewari-Singh N., Capobianco S., Chilian W. M., Zhang C., Tumor necrosis factor- αinduces endothelial dysfunction in Lepr db mice. Circulation 2007 115 2 245 254 2-s2.0-33846194559 10.1161/CIRCULATIONAHA.106.650671
8. Picchi A., Gao X., Belmadani S., Potter B. J., Focardi M., Chilian W. M., Zhang C., Tumor necrosis factor- αinduces endothelial dysfunction in the prediabetic metabolic syndrome. Circulation Research 2006 99 1 69 77 2-s2.0-33746234763 10.1161/01.RES.0000229685.37402.80
9. Kumar A., Takada Y., Boriek A. M., Aggarwal B. B., Nuclear factor- B: its role in health and disease. Journal of Molecular Medicine 2004 82 7 434 448 2-s2.0-3843052483
10. Wolin M. S., Gupte S. A., Oeckler R. A., Superoxide in the vascular system. Journal of Vascular Research 2002 39 3 191 207 2-s2.0-0036311929 10.1159/000063685
11. Griendling K. K., Sorescu D., Lassègue B., Ushio-Fukai M., Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 10 2175 2183 2-s2.0-0033781454
12. Cai H., Harrison D. G., Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circulation Research 2000 87 10 840 844 2-s2.0-0034634281
13. Wagner D. D., Burger P. C., Platelets in inflammation and thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 12 2131 2137 2-s2.0-0347383739 10.1161/01.ATV.0000095974.95122.EC
14. Davì G., Patrono C., Mechanisms of disease: platelet activation and atherothrombosis. New England Journal of Medicine 2007 357 24 2482 2494 2-s2.0-37249068049 10.1056/NEJMra071014
15. Huo Y., Ley K. F., Role of platelets in the development of atherosclerosis. Trends in Cardiovascular Medicine 2004 14 1 18 22 2-s2.0-0347948620 10.1016/j.tcm.2003.09.007
16. Weber C., Platelets and chemokines in atherosclerosis: partners in crime. Circulation Research 2005 96 6 612 616 2-s2.0-16444364523 10.1161/01.RES. 0000160077.17427.57
17. Frenette P. S., Johnson R. C., Hynes R. O., Wagner D. D., Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proceedings of the National Academy of Sciences of the United States of America 1995 92 16 7450 7454 2-s2.0-0029119149 10.1073/pnas.92.16.7450
18. Li G., Sanders J. M., Phan E. T., Ley K., Sarembock I. J., Arterial macrophages and regenerating endothelial cells express P-selectin in atherosclerosis-prone apolipoprotein E-deficient mice. American Journal of Pathology 2005 167 6 1511 1518 2-s2.0-28244491681
19. Libby P., Role of inflammation in atherosclerosis associated with rheumatoid arthritis. American Journal of Medicine 2008 121 10, supplement 1 S21 S31 2-s2.0-52949144507 10.1016/j.amjmed.2008.06.014
20. Solomon D. H., Karlson E. W., Rimm E. B., Cannuscio C. C., Mandl L. A., Manson J. E., Stampfer M. J., Curhan G. C., Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003 107 9 1303 1307 2-s2.0-0037432305 10.1161/01.CIR.0000054612.26458.B2
21. Fischer L. M., Schlienger R. G., Matter C., Jick H., Meier C. R., Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of First-Time acute myocardial infarction. American Journal of Cardiology 2004 93 2 198 200 2-s2.0-0346333033 10.1016/j.amjcard.2003.09.037
22. del Rincon I. D., Williams K., Stern M. P., Freeman G. L., Escalante A., High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis and Rheumatism 2001 44 12 2737 2745
23. Yoshida H., Yilmaz C. E., Granger D. N., Role of tumor necrosis factor-alpha in the extraintestinal thrombosis associated with colonic inflammation. Inflammatory Bowel Diseases 2011 17 11 2217 2223
24. Pircher J., Merkle M., Wornle M., Ribeiro A., Czermak T., Stampnik Y., Mannell H., Niemeyer M., Vielhauer V., Krotz F., Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2. Arthritis Research & Therapy 2012 14 5 R225
25. McVicar D. W., Burshtyn D. N., Intracellular signaling by the killer immunoglobulin-like receptors and Ly49. Science's STKE 2001 2001 75 RE1 2-s2.0-11244332609
26. Dong Q., Siminovitch K. A., Fialkow L., Fukushima T., Downey G. P., Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. Journal of Immunology 1999 162 6 3220 3230 2-s2.0-0033559512
27. Pasquet J. M., Quek L., Pasquet S., Poole A., Matthews J. R., Lowell C., Watson S. P., Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI. Journal of Biological Chemistry 2000 275 37 28526 28531 2-s2.0-0034666158
28. Khaled A. R., Butfiloski E. J., Sobel E. S., Schiffenbauer J., Functional consequences of the SHP-1 defect in motheaten viable mice: role of NF- B. Cellular Immunology 1998 185 1 49 58 2-s2.0-0032502582 10.1006/cimm.1998.1272
29. Krötz F., Engelbrecht B., Buerkle M. A., Bassermann F., Bridell H., Gloe T., Duyster J., Pohl U., Sohn H. Y., The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. Journal of the American College of Cardiology 2005 45 10 1700 1706 2-s2.0-18944384066 10.1016/j.jacc.2005.02.039
30. Pathak M. K., Yi T., Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines. Journal of Immunology 2001 167 6 3391 3397 2-s2.0-0035884996
31. Born G. V. R., Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962 194 4832 927 929 2-s2.0-0346367328 10.1038/194927b0
32. Mannell H., Hammitzsch A., Mettler R., Pohl U., Krötz F., Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt. Cellular Signalling 2010 22 1 88 96 2-s2.0-70349981385 10.1016/j.cellsig.2009.09.015
33. Mannell H. K., Pircher J., Chaudhry D. I., Alig S. K., Koch E. G., Mettler R., Pohl U., Krotz F., ARNO regulates VEGF-dependent tissue responses by stabilizing endothelial VEGFR-2 surface expression. Cardiovascular Research 2012 93 1 111 119
34. Xiao W., Ando T., Wang H. Y., Kawakami Y., Kawakami T., Lyn-and PLC- β 3-dependent regulation of SHP-1 phosphorylation controls Stat5 activity and myelomonocytic leukemia-like disease. Blood 2010 116 26 6003 6013 2-s2.0-78650662553 10.1182/blood-2010-05-283937
35. Takano M., Meneshian A., Sheikh E., Yamakawa Y., Bass Wilkins K., Hopkins E. A., Bulkley G. B., Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation. American Journal of Physiology 2002 283 5 H2054 H2061 2-s2.0-0036839548
36. Patel K. N., Soubra S. H., Bellera R. V., Dong J. F., McMullen C. A., Burns A. R., Rumbaut R. E., Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 12 2225 2230 2-s2.0-57549094163 10.1161/ATVBAHA.108.175679
37. Patel B., Sharifi M., Milward A. D., Oberprieler N. G., Gibbins J. M., Parkin S., Naseem K. M., Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase. Journal of Thrombosis and Haemostasis 2006 4 11 2423 2432 2-s2.0-33750053256 10.1111/j.1538-7836.2006. 02160.x
38. Nakagami H., Cui T. X., Iwai M., Shiuchi T., Takeda-Matsubara Y., Wu L., Horiuchi M., Tumor necrosis factor- αinhibits growth factor-mediated cell proliferation through SHP-1 activation in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 2 238 242 2-s2.0-0036164502 10.1161/hq0202.104001
39. Sugano M., Iwasaki Y., Abe M., Maeda T., Tsuchida K., Makino N., TNF-alpha employs a protein-tyrosine phosphatase to inhibit activation of hepatocyte growth factor receptor and hepatocyte growth factor-induced endothelial cell proliferation. Molecular and Cellular Biochemistry 2009 322 1-2 113 117 2-s2.0-59349091831 10.1007/s11010-008-9946-7
40. Pincheira R., Castro A. F., Ozes O. N., Idumalla P. S., Donner D. B., Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. Journal of Immunology 2008 181 2 1288 1298 2-s2.0-49049106608
41. Somani A. K., Bignon J. S., Mills G. B., Siminovitch K. A., Branch D. R., Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase. Journal of Biological Chemistry 1997 272 34 21113 21119 2-s2.0-0030868305 10.1074/jbc.272.34.21113
42. Siekmeier R., Steffen C., März W., Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations. Journal of Cardiovascular Pharmacology and Therapeutics 2007 12 4 265 282 2-s2.0-37249061358 10.1177/1074248407299519
43. Grassi D., Desideri G., Ferri C., Flavonoids: antioxidants against atherosclerosis. Nutrients 2010 2 8 890 902 2-s2.0-79952066619 10.3390/nu2080889
44. Mann D. L., Targeted anticytokine therapy and the failing heart. American Journal of Cardiology 2005 95 11 9C 16C 2-s2.0-19944386296 10.1016/j.amjcard. 2005.03.007
45. Sugano M., Tsuchida K., Hata T., Makino N., RNA interference targeting SHP-1 attenuates myocardial infarction in rats. FASEB Journal 2005 19 14 2054 2056 2-s2.0-28744450235 10.1096/fj.05-4020fje
46. Beamer C. A., Brooks D. M., Lurie D. I., Motheaten (me/me) mice deficient in SHP-1 are less susceptible to focal cerebral ischemia. Journal of Neuroscience Research 2006 83 7 1220 1230 2-s2.0-33646371002 10.1002/jnr.20825
47. Won Y.-W., Lee M., Kim H. A., Bull D. A., Kim S. W., Hypoxia-inducible plasmid expressing both miSHP-1 and HO-1 for the treatment of ischemic disease. Journal of Controlled Release 2013 165 1 22 28 10.1016/j.jconrel.2012.10.014
48. Vercauteren M., Remy E., Devaux C., Dautreaux B., Henry J. P., Bauer F., Mulder P., Van Huijsduijnen R. H., Bombrun A., Thuillez C., Richard V., Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation 2006 114 23 2498 2507 2-s2.0-33845391536 10.1161/CIRCULATIONAHA.106.630129